Tokyo, Jan. 31 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060521) titled 'Clinical Performance Study of a Novel Multigene Panel Test(BRANCH Ancillary Study 01)' on Jan. 30.
Study Type:
Observational
Primary Sponsor:
Institute - National Cancer Center Hospital East
Condition:
Condition - Breast cancer, pancreatic cancer, prostate cancer, ovarian cancer, other gynecologic cancers, retroperitoneal or peritoneal tumors
Classification by malignancy - Malignancy
Genomic information - YES
Objective:
Narrative objectives1 - As an ancillary study of the BRANCH study, this clinical performance study will be conducted using residual specimens from patients with solid tumors enrolled in Cohort D, ...